Consumer wearable devices provide clinical information similar to hospital assessment of heart disease

FHS
July 15, 2024
6:52 pm

Monitoring of heart rate and physical activity using consumer wearable devices was found to have clinical value for comparing the response to two treatments for atrial fibrillation and heart failure.

NICE recommends Idorsia’s chronic insomnia treatment for UK patients – Pharmaceutical Technology

The drug works by selectively blocking receptors in the brain that are important in promoting wakefulness. Image credit: Shutterstock/Tero Vesalainen. Adults in England and Wales

September 15, 2023

Susan Tousi leaves Illumina to become CEO of liquid biopsy firm Delfi

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Susan Tousi, CEO of Delfi Diagnostics Courtesy of

January 9, 2024

Yale scientists identify drug target that may alleviate joint degeneration in osteoarthritis

Yale researchers have identified a drug target that may alleviate joint degeneration associated with osteoarthritis, a debilitating condition that afflicts as many as 30 million

January 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.